Free Cash Flow

The frac sand supplier's special dividend highlights a strong balance sheet and a dual-market strategy, but how does it stack up in a competitive field?

TMSH announces a transformative eyewear deal for its subsidiary, but research reveals the vintage brand's focus was apparel just weeks ago.

Roadzen's newly patented AI fuses sensor data with video to map road hazards in real-time, promising safer roads, smarter fleets, and a new era of mobility.

Healthcare M&A firm JW Advisory hires a key leader to expand West, aiming to professionalize practice sales in a rapidly consolidating market.

HFS Research names Ascendion a market leader for turning AI hype into reality, delivering massive savings and productivity gains with its agentic platform.

A defense giant's survivability tech, honed for soldiers, now protects astronauts on NASA's Orion spacecraft. See how it bridges two high-stakes frontiers.

As drug-resistant superbugs threaten modern medicine, a novel liquid therapeutic from Seres Therapeutics offers a lifeline for the most vulnerable patients.

UPM holds its dividend steady while new board appointments and major capital authorizations signal a clear focus on strategic growth and transformation.

The miner reports robust Q1 gold output, driven by its Séguéla mine, while advancing key growth projects and returning significant cash to shareholders.

Activist investor Veradace Partners demands Repay scrap its KUBRA deal, alleging a breach of fiduciary duty and widespread shareholder opposition.

With a massive $425M credit facility, LiveOak Fiber is set to supercharge its internet expansion in Florida and Georgia, challenging giants with a local focus.

New research reveals a third of B2B companies waste millions on unmeasured go-to-market strategies, creating a stark divide between winners and losers.

Matmut Group shatters records with a 56% profit surge, but its transformative acquisition of KOREGE signals a major strategic shift into savings and protection.

With its European trial launch, Kainova's DT-7012 aims to disarm cancer's bodyguards, offering new hope for patients with advanced solid tumors.

China's EdTech giant TAL is set to report Q4 earnings. Investors are watching closely to see if its pivot to AI and smart devices is a winning strategy.

A Texas firm opens a plant for a non-toxic chemical that boosts oil output and could turn old wells into a new source of critical minerals.

ADP's latest dividend declaration highlights its financial strength and commitment to shareholders, cementing its status as a reliable income-generating stock.

As Spectral AI preps its revolutionary DeepView wound scanner for launch, new CFO David McGuire brings crucial public company expertise to a pivotal transition.

After a Nasdaq delisting for compliance failures, Captivision is abandoning its tech past for a risky new venture: a gold rush in Montana.

With its future riding on a pivotal trial for avexitide, Amylyx's upcoming conference presentation offers a crucial look into its post-ALS strategy.